Human Genome Epidemiology Literature Finder
|
Records 1 - 2 (of 2 Records) |
| Query Trace: Myocardial Infarction and GRK4[original query] |
|---|
| G protein receptor kinase 4 polymorphisms: ß-blocker pharmacogenetics and treatment-related outcomes in hypertension. Hypertension 2012 Oct 60 (4): 957-64. Vandell Alexander G, Lobmeyer Maximilian T, Gawronski Brian E, Langaee Taimour Y, Gong Yan, Gums John G, Beitelshees Amber L, Turner Stephen T, Chapman Arlene B, Cooper-DeHoff Rhonda M, Bailey Kent R, Boerwinkle Eric, Pepine Carl J, Liggett Stephen B, Johnson Julie |
| Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy. Clinical pharmacology and therapeutics 2024 7 . Julio D Duarte, Cameron D Thomas, Craig R Lee, Rachel Huddart, Jose A G Agundez, Jordan F Baye, Andrea Gaedigk, Teri E Klein, David E Lanfear, Andrew A Monte, Mohamed Nagy, Matthias Schwab, C Michael Stein, Chakradhara Rao S Uppugunduri, Ron H N van Schaik, Roseann S Donnelly, Kelly E Caudle, Jasmine A Luz |
- Page last reviewed:Feb 1, 2024
- Content source:

